ArticleBlood2008

Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells.

Rosa Lapalombella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.